Market Executive Summary
A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.
The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.
Due to the COVID-19 pandemic, the global Covid-19 Vaccine Market size was --US$ million in 2024 and is forecast to a readjusted size of --US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Fully considering the economic change by this health crisis, DNA accounting for % of the Covid-19 Vaccine global market in 2022, is projected to value US$ million by 2029, growing at a revised ?GR from 2023 to 2029. While Adults segment is altered to an ?GR throughout this forecast period.
North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Covid-19 Vaccine market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Covid-19 Vaccine market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Covid-19 Vaccine market. Readers of the report can become informed about current and future trends of the global Covid-19 Vaccine market and how they will impact market growth during the forecast period.
Global Covid-19 Vaccine Companies Covered
Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson?Johnson, Heat Biologics, Sanofi
Global Covid-19 Vaccine Market by Type:
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Global Covid-19 Vaccine Market by Application
Adults
Children
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Covid-19 Vaccine in global and regional level.
Chapter 3: Detailed analysis of Covid-19 Vaccine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid-19 Vaccine revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion.
Related Reports:
Global Antibody-drug Conjugates Market Size, Share, Opportunities, Competitive Landscape, Key Players, Growth Drivers, Trends, Revenue Analysis, and Demand Forecast to 2032
Global Drug Discovery Assays Market Size, Share, Competitive Analysis, Key Players, Growth Drivers, Trends, Opportunities, Revenue Analysis, and Demand Forecast to 2032
Global Psychedelic Drugs Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Analysis, Overall Sales and Demand Forecast To 2030
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Vaccine Market Growth Rate by Application: 2018 VS 2022 VS 2029
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Covid-19 Vaccine Market Size (2018-2029)
2.2 Covid-19 Vaccine Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029
2.3 Global Covid-19 Vaccine Market Size by Region (2018-2023)
2.4 Global Covid-19 Vaccine Market Size Forecast by Region (2024-2029)
2.5 Global Top 10 Covid-19 Vaccine Countries Ranking by Market Size
3 Covid-19 Vaccine Competitive by Company
3.1 Global Covid-19 Vaccine Revenue by Players
3.1.1 Global Covid-19 Vaccine Revenue by Players (2018-2023)
3.1.2 Global Covid-19 Vaccine Market Share by Players (2018-2023)
3.2 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Covid-19 Vaccine Revenue
3.4 Global Covid-19 Vaccine Market Concentration Ratio
3.4.1 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Vaccine Revenue in 2022
3.5 Global Key Players of Covid-19 Vaccine Head office and Area Served
3.6 Global Key Players of Covid-19 Vaccine, Product and Application
3.7 Global Key Players of Covid-19 Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Covid-19 Vaccine Breakdown Data by Type
4.1 Global Covid-19 Vaccine Historic Revenue by Type (2018-2023)
4.2 Global Covid-19 Vaccine Forecasted Revenue by Type (2024-2029)
5 Global Covid-19 Vaccine Breakdown Data by Application
5.1 Global Covid-19 Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Covid-19 Vaccine Revenue by Company (2021-2023)
6.2 North America Covid-19 Vaccine Revenue by Type (2018-2029)
6.3 North America Covid-19 Vaccine Revenue by Application (2018-2029)
6.4 North America Covid-19 Vaccine Revenue by Country (2018-2029)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Covid-19 Vaccine Revenue by Company (2021-2023)
7.2 Europe Covid-19 Vaccine Revenue by Type (2018-2029)
7.3 Europe Covid-19 Vaccine Revenue by Application (2018-2029)
7.4 Europe Covid-19 Vaccine Revenue by Country (2018-2029)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Covid-19 Vaccine Revenue by Company (2021-2023)
8.2 Asia Pacific Covid-19 Vaccine Revenue by Type (2018-2029)
8.3 Asia Pacific Covid-19 Vaccine Revenue by Application (2018-2029)
8.4 Asia Pacific Covid-19 Vaccine Revenue by Region (2018-2029)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Covid-19 Vaccine Revenue by Company (2021-2023)
9.2 Latin America Covid-19 Vaccine Revenue by Type (2018-2029)
9.3 Latin America Covid-19 Vaccine Revenue by Application (2018-2029)
9.4 Latin America Covid-19 Vaccine Revenue by Country (2018-2029)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Covid-19 Vaccine Revenue by Company (2021-2023)
10.2 Middle East and Africa Covid-19 Vaccine Revenue by Type (2018-2029)
10.3 Middle East and Africa Covid-19 Vaccine Revenue by Application (2018-2029)
10.4 Middle East and Africa Covid-19 Vaccine Revenue by Country (2018-2029)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Moderna
11.1.1 Moderna Company Details
11.1.2 Moderna Business Overview
11.1.3 Moderna Covid-19 Vaccine Products and Services
11.1.4 Moderna Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023)
11.1.5 Moderna Covid-19 Vaccine SWOT Analysis
11.1.6 Moderna Recent Development
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Company Details
11.2.2 CanSino Biologicals Business Overview
11.2.3 CanSino Biologicals Covid-19 Vaccine Products and Services
11.2.4 CanSino Biologicals Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023)
11.2.5 CanSino Biologicals Covid-19 Vaccine SWOT Analysis
11.2.6 CanSino Biologicals Recent Development
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Company Details
11.3.2 Inovio Pharmaceuticals Business Overview
11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Products and Services
11.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023)
11.3.5 Inovio Pharmaceuticals Covid-19 Vaccine SWOT Analysis
11.3.6 Inovio Pharmaceuticals Recent Development
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Company Details
11.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Products and Services
11.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023)
11.4.5 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine SWOT Analysis
11.4.6 Shenzhen Geno-Immune Medical Institute Recent Development
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Company Details
11.5.2 GlaxoSmithKine Business Overview
11.5.3 GlaxoSmithKine Covid-19 Vaccine Products and Services
11.5.4 GlaxoSmithKine Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023)
11.5.5 GlaxoSmithKine Covid-19 Vaccine SWOT Analysis
11.5.6 GlaxoSmithKine Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Covid-19 Vaccine Products and Services
11.6.4 Pfizer Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023)
11.6.5 Pfizer Covid-19 Vaccine SWOT Analysis
11.6.6 Pfizer Recent Development
11.7 Johnson?Johnson
11.7.1 Johnson?Johnson Company Details
11.7.2 Johnson?Johnson Business Overview
11.7.3 Johnson?Johnson Covid-19 Vaccine Products and Services
11.7.4 Johnson?Johnson Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023)
11.7.5 Johnson?Johnson Covid-19 Vaccine SWOT Analysis
11.7.6 Johnson?Johnson Recent Development
11.8 Heat Biologics
11.8.1 Heat Biologics Company Details
11.8.2 Heat Biologics Business Overview
11.8.3 Heat Biologics Covid-19 Vaccine Products and Services
11.8.4 Heat Biologics Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023)
11.8.5 Heat Biologics Covid-19 Vaccine SWOT Analysis
11.8.6 Heat Biologics Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Covid-19 Vaccine Products and Services
11.9.4 Sanofi Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023)
11.9.5 Sanofi Covid-19 Vaccine SWOT Analysis
11.9.6 Sanofi Recent Development
12 Covid-19 Vaccine Market Dynamics
12.1 Covid-19 Vaccine Industry Trends
12.2 Covid-19 Vaccine Market Drivers
12.3 Covid-19 Vaccine Market Challenges
12.4 Covid-19 Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures
List of Tables
Table 1. Global Covid-19 Vaccine Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of DNA
Table 3. Key Players of Non-replicating Viral Vector
Table 4. Key Players of Protein Subunit
Table 5. Key Players of RNA
Table 6. Key Players of Others
Table 7. Global Covid-19 Vaccine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Covid-19 Vaccine Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
Table 9. Global Covid-19 Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Covid-19 Vaccine Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 11. Global Covid-19 Vaccine Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Table 12. Global Covid-19 Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 13. Global Covid-19 Vaccine Market Share by Players (2018-2023)
Table 14. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2022)
Table 15. Ranking of Global Top Covid-19 Vaccine Companies by Revenue (US$ Million) in 2022
Table 16. Global 5 Largest Players Market Share by Covid-19 Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 17. Global Key Players of Covid-19 Vaccine, Headquarters and Area Served
Table 18. Global Key Players of Covid-19 Vaccine, Product and Application
Table 19. Global Key Players of Covid-19 Vaccine, Date of Enter into This Industry
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Covid-19 Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 22. Global Covid-19 Vaccine Revenue Market Share by Type (2018-2023)
Table 23. Global Covid-19 Vaccine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 24. Global Covid-19 Vaccine Revenue Market Share by Type (2024-2029)
Table 25. Global Covid-19 Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 26. Global Covid-19 Vaccine Revenue Market Share by Application (2018-2023)
Table 27. Global Covid-19 Vaccine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 28. Global Covid-19 Vaccine Revenue Market Share by Application (2024-2029)
Table 29. North America Covid-19 Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 30. North America Covid-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 31. North America Covid-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 32. North America Covid-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 33. North America Covid-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 34. North America Covid-19 Vaccine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Covid-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 36. North America Covid-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 37. Europe Covid-19 Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 38. Europe Covid-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 39. Europe Covid-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 40. Europe Covid-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 41. Europe Covid-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 42. Europe Covid-19 Vaccine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Covid-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Europe Covid-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Asia Pacific Covid-19 Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 46. Asia Pacific Covid-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 47. Asia Pacific Covid-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 48. Asia Pacific Covid-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 49. Asia Pacific Covid-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 50. Asia-Pacific Covid-19 Vaccine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 51. Asia Pacific Covid-19 Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 52. Asia Pacific Covid-19 Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 53. Latin America Covid-19 Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 54. Latin America Covid-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 55. Latin America Covid-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 56. Latin America Covid-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 57. Latin America Covid-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 58. Latin America Covid-19 Vaccine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 59. Latin America Covid-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 60. Latin America Covid-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 61. Middle East and Africa Covid-19 Vaccine Revenue by Company (2021-2023) & (US$ Million)
Table 62. Middle East and Africa Covid-19 Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 63. Middle East and Africa Covid-19 Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Middle East and Africa Covid-19 Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Covid-19 Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 66. Middle East and Africa Covid-19 Vaccine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 67. Middle East and Africa Covid-19 Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 68. Middle East and Africa Covid-19 Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 69. Moderna Company Details
Table 70. Moderna Business Overview
Table 71. Moderna Covid-19 Vaccine Product and Services
Table 72. Moderna Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 73. Moderna Covid-19 Vaccine SWOT Analysis
Table 74. Moderna Recent Development
Table 75. CanSino Biologicals Company Details
Table 76. CanSino Biologicals Business Overview
Table 77. CanSino Biologicals Covid-19 Vaccine Product and Services
Table 78. CanSino Biologicals Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 79. CanSino Biologicals Covid-19 Vaccine SWOT Analysis
Table 80. CanSino Biologicals Recent Development
Table 81. Inovio Pharmaceuticals Company Details
Table 82. Inovio Pharmaceuticals Business Overview
Table 83. Inovio Pharmaceuticals Covid-19 Vaccine Product and Services
Table 84. Inovio Pharmaceuticals Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 85. Inovio Pharmaceuticals Covid-19 Vaccine SWOT Analysis
Table 86. Inovio Pharmaceuticals Recent Development
Table 87. Shenzhen Geno-Immune Medical Institute Company Details
Table 88. Shenzhen Geno-Immune Medical Institute Business Overview
Table 89. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product and Services
Table 90. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 91. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine SWOT Analysis
Table 92. Shenzhen Geno-Immune Medical Institute Recent Development
Table 93. GlaxoSmithKine Company Details
Table 94. GlaxoSmithKine Business Overview
Table 95. GlaxoSmithKine Covid-19 Vaccine Product and Services
Table 96. GlaxoSmithKine Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 97. GlaxoSmithKine Covid-19 Vaccine SWOT Analysis
Table 98. GlaxoSmithKine Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Covid-19 Vaccine Product and Services
Table 102. Pfizer Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 103. Pfizer Covid-19 Vaccine SWOT Analysis
Table 104. Pfizer Recent Development
Table 105. Johnson?Johnson Company Details
Table 106. Johnson?Johnson Business Overview
Table 107. Johnson?Johnson Covid-19 Vaccine Product and Services
Table 108. Johnson?Johnson Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 109. Johnson?Johnson Covid-19 Vaccine SWOT Analysis
Table 110. Johnson?Johnson Recent Development
Table 111. Heat Biologics Company Details
Table 112. Heat Biologics Business Overview
Table 113. Heat Biologics Covid-19 Vaccine Product and Services
Table 114. Heat Biologics Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 115. Heat Biologics Covid-19 Vaccine SWOT Analysis
Table 116. Heat Biologics Recent Development
Table 117. Sanofi Company Details
Table 118. Sanofi Business Overview
Table 119. Sanofi Covid-19 Vaccine Product and Services
Table 120. Sanofi Covid-19 Vaccine Revenue in Covid-19 Vaccine Business (2018-2023) & (US$ Million)
Table 121. Sanofi Covid-19 Vaccine SWOT Analysis
Table 122. Sanofi Recent Development
Table 123. Covid-19 Vaccine Market Trends
Table 124. Covid-19 Vaccine Market Drivers
Table 125. Covid-19 Vaccine Market Challenges
Table 126. Covid-19 Vaccine Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Covid-19 Vaccine Product Picture
Figure 2. Global Covid-19 Vaccine Market Size by Type (US$ Million): 2018 VS 2022 VS 2029
Figure 3. Global Covid-19 Vaccine Market Share by Type: 2022 VS 2029
Figure 4. DNA Features
Figure 5. Non-replicating Viral Vector Features
Figure 6. Protein Subunit Features
Figure 7. RNA Features
Figure 8. Others Features
Figure 9. Global Covid-19 Vaccine Market Size by Application (US$ Million): 2018 VS 2022 VS 2029
Figure 10. Global Covid-19 Vaccine Market Share by Application: 2022 VS 2029
Figure 11. Adults
Figure 12. Children
Figure 13. Covid-19 Vaccine Report Years Considered
Figure 14. Global Covid-19 Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Covid-19 Vaccine Market Size 2018-2029 (US$ Million)
Figure 16. Global Covid-19 Vaccine Market Size Market Share by Region: 2022 VS 2029
Figure 17. Global Covid-19 Vaccine Revenue Market Share by Region in 2018 VS 2022
Figure 18. Global Covid-19 Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 19. Global Top 10 Covid-19 Vaccine Countries Ranking by Market Size (US$ Million) in 2022
Figure 20. Global Covid-19 Vaccine Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Figure 21. Global Covid-19 Vaccine Market Share by Players in 2022
Figure 22. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2022
Figure 24. North America Covid-19 Vaccine Revenue Market Share by Company in 2022
Figure 25. North America Covid-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 26. North America Covid-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 27. North America Covid-19 Vaccine Revenue Share by Country (2018-2029)
Figure 28. U.S. Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 29. Canada Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 30. Europe Covid-19 Vaccine Revenue Market Share by Company in 2022
Figure 31. Europe Covid-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Europe Covid-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 33. Europe Covid-19 Vaccine Revenue Share by Country (2018-2029)
Figure 34. Germany Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 35. France Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 36. U.K. Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 37. Italy Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 38. Russia Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 39. Asia Pacific Covid-19 Vaccine Revenue Market Share by Company in 2022
Figure 40. Asia Pacific Covid-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 41. Asia Pacific Covid-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 42. Asia Pacific Covid-19 Vaccine Revenue Share by Region (2018-2029)
Figure 43. China Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Japan Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 45. South Korea Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 46. India Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 47. Australia Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 48. China Taiwan Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. Indonesia Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. Thailand Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Malaysia Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Latin America Covid-19 Vaccine Revenue Market Share by Company in 2022
Figure 53. Latin America Covid-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 54. Latin America Covid-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 55. Latin America Covid-19 Vaccine Revenue Share by Country (2018-2029)
Figure 56. Mexico Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 57. Brazil Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 58. Argentina Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 59. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Company in 2022
Figure 60. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Covid-19 Vaccine Revenue Share by Country (2018-2029)
Figure 63. Turkey Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. Saudi Arabia Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. UAE Covid-19 Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Moderna Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 67. CanSino Biologicals Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 68. Inovio Pharmaceuticals Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 69. Shenzhen Geno-Immune Medical Institute Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 70. GlaxoSmithKine Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 71. Pfizer Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 72. Johnson?Johnson Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 73. Heat Biologics Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 74. Sanofi Revenue Growth Rate in Covid-19 Vaccine Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
